Former U.S. President Joe Biden, 82, has been diagnosed with an aggressive form of prostate cancer that has spread to his bones, according to a statement from his office released Sunday. The diagnosis was made following a medical evaluation prompted by urinary symptoms, which led to the discovery of a prostate nodule. Further testing revealed a Gleason score of 9, indicating a high-grade, rapidly progressing cancer.
Despite the seriousness of the condition, Biden’s medical team emphasized that the cancer is hormone-sensitive—a characteristic that allows for several potentially effective treatment options. Biden and his family are currently in consultation with a team of specialists to determine the most appropriate course of action.
Biden, who left office in January 2025 after serving one term, has long been a passionate advocate in the fight against cancer. He spearheaded initiatives such as the Cancer Moonshot during his time in office and throughout his decades in public service.
Following the announcement, President Donald Trump issued a public message wishing Biden a "fast and successful recovery." Vice President Kamala Harris also voiced her support, expressing confidence in Biden's strength and resilience in the face of the diagnosis.
The news has sparked widespread concern and sympathy across political lines, with many praising Biden’s longstanding commitment to advancing cancer research and support for patients. His diagnosis brings renewed attention to prostate cancer, particularly in older men, highlighting the importance of early detection and regular screenings.
As the former president prepares to undergo treatment, updates on his condition are expected in the coming weeks. His office has requested privacy while medical decisions are being made. Biden’s legacy as a cancer advocate remains a central part of his public life, now underscored by his personal battle with the disease.


Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
US Pushes Ukraine-Russia Peace Talks Before Summer Amid Escalating Attacks
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
U.S. Announces Additional $6 Million in Humanitarian Aid to Cuba Amid Oil Sanctions and Fuel Shortages
Netanyahu to Meet Trump in Washington as Iran Nuclear Talks Intensify 



